Ayaan A Alam
Examiner (ID: 3803)
Most Active Art Unit | 1611 |
Art Unit(s) | 1611 |
Total Applications | 153 |
Issued Applications | 27 |
Pending Applications | 65 |
Abandoned Applications | 61 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 1546754
[patent_doc_number] => 06444873
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'MSH5 ablated mice and uses therefor'
[patent_app_type] => B1
[patent_app_number] => 09/469636
[patent_app_country] => US
[patent_app_date] => 1999-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 35
[patent_no_of_words] => 8672
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444873.pdf
[firstpage_image] =>[orig_patent_app_number] => 09469636
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/469636 | MSH5 ablated mice and uses therefor | Dec 21, 1999 | Issued |
Array
(
[id] => 4324239
[patent_doc_number] => 06331614
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-18
[patent_title] => 'Human CDC14A gene'
[patent_app_type] => 1
[patent_app_number] => 9/468872
[patent_app_country] => US
[patent_app_date] => 1999-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 33771
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/331/06331614.pdf
[firstpage_image] =>[orig_patent_app_number] => 468872
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/468872 | Human CDC14A gene | Dec 21, 1999 | Issued |
Array
(
[id] => 1508472
[patent_doc_number] => 06441156
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Calcium channel compositions and methods of use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/470443
[patent_app_country] => US
[patent_app_date] => 1999-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 45964
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/441/06441156.pdf
[firstpage_image] =>[orig_patent_app_number] => 09470443
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/470443 | Calcium channel compositions and methods of use thereof | Dec 21, 1999 | Issued |
09/466139 | PROTEIN-PROTEIN INTERACTIONS IN NEURODEGENERATIVE DISORDERS | Dec 20, 1999 | Abandoned |
Array
(
[id] => 5890458
[patent_doc_number] => 20020013952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-31
[patent_title] => 'Self-contained system for sustained viral replication'
[patent_app_type] => new
[patent_app_number] => 09/460555
[patent_app_country] => US
[patent_app_date] => 1999-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 14816
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20020013952.pdf
[firstpage_image] =>[orig_patent_app_number] => 09460555
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/460555 | Self-contained system for sustained viral replication | Dec 13, 1999 | Issued |
60/287581 | BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE | Dec 13, 1999 | Pending |
Array
(
[id] => 6698330
[patent_doc_number] => 20030110524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'TRANSGENIC ORGANISMS AND THEIR USES'
[patent_app_type] => new
[patent_app_number] => 09/460559
[patent_app_country] => US
[patent_app_date] => 1999-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8470
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20030110524.pdf
[firstpage_image] =>[orig_patent_app_number] => 09460559
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/460559 | TRANSGENIC ORGANISMS AND THEIR USES | Dec 13, 1999 | Abandoned |
09/455367 | BETA PEPTIDE SCREENING ASSAY | Dec 2, 1999 | Abandoned |
Array
(
[id] => 1587309
[patent_doc_number] => 06359193
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-19
[patent_title] => 'Nucleotide sequences of lats genes'
[patent_app_type] => B1
[patent_app_number] => 09/442100
[patent_app_country] => US
[patent_app_date] => 1999-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 15
[patent_no_of_words] => 51549
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/359/06359193.pdf
[firstpage_image] =>[orig_patent_app_number] => 09442100
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/442100 | Nucleotide sequences of lats genes | Nov 16, 1999 | Issued |
Array
(
[id] => 6349367
[patent_doc_number] => 20020035733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'CONGENIC ANIMAL MODELS OF NON-INSULIN DEPENDENT DIABETES MELLITUS'
[patent_app_type] => new
[patent_app_number] => 09/434066
[patent_app_country] => US
[patent_app_date] => 1999-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14654
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20020035733.pdf
[firstpage_image] =>[orig_patent_app_number] => 09434066
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/434066 | Congenic animal models of non-insulin dependent diabetes mellitus | Nov 4, 1999 | Issued |
Array
(
[id] => 4288745
[patent_doc_number] => 06235524
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-22
[patent_title] => 'Compositions and methods for screening agents that inhibit MAPK mediated anti-apoptotic signals'
[patent_app_type] => 1
[patent_app_number] => 9/431573
[patent_app_country] => US
[patent_app_date] => 1999-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 15
[patent_no_of_words] => 13612
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/235/06235524.pdf
[firstpage_image] =>[orig_patent_app_number] => 431573
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/431573 | Compositions and methods for screening agents that inhibit MAPK mediated anti-apoptotic signals | Oct 28, 1999 | Issued |
Array
(
[id] => 4307982
[patent_doc_number] => 06252132
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-26
[patent_title] => 'Mutant mouse containing a knockout mutation in DNA encoding an endogenous alpha 4 subunit of nicotinic acetylcholine receptor'
[patent_app_type] => 1
[patent_app_number] => 9/427581
[patent_app_country] => US
[patent_app_date] => 1999-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 8006
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/252/06252132.pdf
[firstpage_image] =>[orig_patent_app_number] => 427581
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/427581 | Mutant mouse containing a knockout mutation in DNA encoding an endogenous alpha 4 subunit of nicotinic acetylcholine receptor | Oct 26, 1999 | Issued |
Array
(
[id] => 4355614
[patent_doc_number] => 06218372
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-17
[patent_title] => 'Methods for treating restenosis with p21'
[patent_app_type] => 1
[patent_app_number] => 9/426325
[patent_app_country] => US
[patent_app_date] => 1999-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6013
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/218/06218372.pdf
[firstpage_image] =>[orig_patent_app_number] => 426325
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/426325 | Methods for treating restenosis with p21 | Oct 24, 1999 | Issued |
Array
(
[id] => 1447670
[patent_doc_number] => 06369295
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-09
[patent_title] => 'Uses of transgenic mouse containing a type X collagen mutant'
[patent_app_type] => B1
[patent_app_number] => 09/415551
[patent_app_country] => US
[patent_app_date] => 1999-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 17
[patent_no_of_words] => 11440
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/369/06369295.pdf
[firstpage_image] =>[orig_patent_app_number] => 09415551
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/415551 | Uses of transgenic mouse containing a type X collagen mutant | Oct 7, 1999 | Issued |
Array
(
[id] => 4406878
[patent_doc_number] => 06300084
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-09
[patent_title] => 'Anti-mitotic agent screening process'
[patent_app_type] => 1
[patent_app_number] => 9/414828
[patent_app_country] => US
[patent_app_date] => 1999-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9727
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/300/06300084.pdf
[firstpage_image] =>[orig_patent_app_number] => 414828
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/414828 | Anti-mitotic agent screening process | Oct 5, 1999 | Issued |
09/407356 | 23431, A NOVEL HUMAN UBIQUITIN PROTEASE | Sep 28, 1999 | Abandoned |
Array
(
[id] => 1377262
[patent_doc_number] => 06563017
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-05-13
[patent_title] => 'In vivo electroporation method for early stage embryo of chickens'
[patent_app_type] => B2
[patent_app_number] => 09/214565
[patent_app_country] => US
[patent_app_date] => 1999-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2226
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/563/06563017.pdf
[firstpage_image] =>[orig_patent_app_number] => 09214565
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/214565 | In vivo electroporation method for early stage embryo of chickens | Sep 12, 1999 | Issued |
Array
(
[id] => 1477801
[patent_doc_number] => 06451594
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-17
[patent_title] => 'Recombinant adenovirus for tissue specific expression in heart'
[patent_app_type] => B1
[patent_app_number] => 09/394110
[patent_app_country] => US
[patent_app_date] => 1999-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 6276
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/451/06451594.pdf
[firstpage_image] =>[orig_patent_app_number] => 09394110
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/394110 | Recombinant adenovirus for tissue specific expression in heart | Sep 9, 1999 | Issued |
Array
(
[id] => 6211844
[patent_doc_number] => 20020073440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-13
[patent_title] => 'METHOD FOR SCREENING AND TRANSGENIC MODEL'
[patent_app_type] => new
[patent_app_number] => 09/367272
[patent_app_country] => US
[patent_app_date] => 1999-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4728
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20020073440.pdf
[firstpage_image] =>[orig_patent_app_number] => 09367272
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/367272 | METHOD FOR SCREENING AND TRANSGENIC MODEL | Sep 8, 1999 | Abandoned |
Array
(
[id] => 1313320
[patent_doc_number] => 06613957
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-02
[patent_title] => 'Synthesis of functional human hemoglobin and other proteins in erythroid tissues of transgenic non-human mammals'
[patent_app_type] => B1
[patent_app_number] => 09/388401
[patent_app_country] => US
[patent_app_date] => 1999-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 32
[patent_no_of_words] => 19060
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/613/06613957.pdf
[firstpage_image] =>[orig_patent_app_number] => 09388401
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/388401 | Synthesis of functional human hemoglobin and other proteins in erythroid tissues of transgenic non-human mammals | Aug 31, 1999 | Issued |